Molecular epidemiology of human herpesvirus 8 variants in Kaposi's sarcoma from Iranian patients.

PubWeight™: 0.81‹?›

🔗 View Article (PMID 21963664)

Published in Virus Res on September 22, 2011

Authors

Somayeh Jalilvand1, Maria Lina Tornesello, Franco M Buonaguro, Luigi Buonaguro, Zahra Safaie Naraghi, Zabihollah Shoja, Abed-Ali Ziaee, Rasool Hamkar, Shohreh Shahmahmoodi, Rakhshandeh Nategh, Talat Mokhtari-Azad

Author Affiliations

1: School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.

Articles by these authors

Classification of weakly carcinogenic human papillomavirus types: addressing the limits of epidemiology at the borderline. Infect Agent Cancer (2009) 3.33

Influenza A (H1N1) pandemic in Iran: report of first confirmed cases from June to November 2009. Arch Iran Med (2010) 2.03

Role of PTEN gene in progression of prostate cancer. Urol J (2007) 1.69

The role of human papillomavirus infection in prostate carcinoma. Scand J Infect Dis (2010) 1.64

Detection of hepatitis G virus envelope protein E2 antibody in blood donors. Int J Infect Dis (2007) 1.48

Opioid receptors control viral replication in the airways. Crit Care Med (2013) 1.43

Molecular epidemiology of hepatitis C virus in Iran as reflected by phylogenetic analysis of the NS5B region. J Med Virol (2004) 1.38

Identification of squamous cell carcinoma associated proteins by proteomics and loss of beta tropomyosin expression in esophageal cancer. World J Gastroenterol (2006) 1.30

Mutations in TP53, CTNNB1 and PIK3CA genes in hepatocellular carcinoma associated with hepatitis B and hepatitis C virus infections. Genomics (2013) 1.24

Evaluation of a combined triple method to detect causative HPV in oral and oropharyngeal squamous cell carcinomas: p16 Immunohistochemistry, Consensus PCR HPV-DNA, and In Situ Hybridization. Infect Agent Cancer (2012) 1.17

Analysis of human papillomavirus type-16 variants in Italian women with cervical intraepithelial neoplasia and cervical cancer. J Med Virol (2004) 1.13

Seroprevalence of Human herpesvirus 8 (HHV-8) and incidence of Kaposi's sarcoma in Iran. Infect Agent Cancer (2011) 1.13

Evaluation of rubella IgM enzyme immunoassays. J Clin Virol (2004) 1.11

Purification and characterization of an organic-solvent-tolerant halophilic α-amylase from the moderately halophilic Nesterenkonia sp. strain F. J Ind Microbiol Biotechnol (2010) 1.10

Translating tumor antigens into cancer vaccines. Clin Vaccine Immunol (2010) 1.09

Molecular signatures associated with HCV-induced hepatocellular carcinoma and liver metastasis. PLoS One (2013) 1.06

Strengthening the influenza vaccine virus selection and development process: outcome of the 2nd WHO Informal Consultation for Improving Influenza Vaccine Virus Selection held at the Centre International de Conférences (CICG) Geneva, Switzerland, 7 to 9 December 2011. Vaccine (2013) 1.05

Update on Head and Neck Cancer: Current Knowledge on Epidemiology, Risk Factors, Molecular Features and Novel Therapies. Oncology (2015) 1.03

Prevalence of alpha-papillomavirus genotypes in cervical squamous intraepithelial lesions and invasive cervical carcinoma in the Italian population. J Med Virol (2006) 1.02

Assessment of IgM enzyme immunoassay and IgG avidity assay for distinguishing between primary and secondary immune response to rubella vaccine. J Virol Methods (2005) 1.02

Incidence of breast cancer in Italy: mastectomies and quadrantectomies performed between 2000 and 2005. J Exp Clin Cancer Res (2009) 1.02

Prevalence of human papillomavirus types in high-grade cervical intraepithelial neoplasia and cancer in Italy. Cancer Epidemiol Biomarkers Prev (2010) 1.00

Pandemic 2009 influenza A (H1N1) infection among 2009 Hajj Pilgrims from Southern Iran: a real-time RT-PCR-based study. Influenza Other Respir Viruses (2012) 0.99

Environmental surveillance of Non-Polio Enteroviruses in Iran. Virol J (2009) 0.99

Human papillomavirus genotypes and HPV16 variants in penile carcinoma. Int J Cancer (2008) 0.99

Effects of adjuvants on IgG subclasses elicited by virus-like particles. J Transl Med (2012) 0.99

Immature monocyte derived dendritic cells gene expression profile in response to Virus-Like Particles stimulation. J Transl Med (2005) 0.98

Immunization with M2e-displaying T7 bacteriophage nanoparticles protects against influenza A virus challenge. PLoS One (2012) 0.97

Mutations of the TP53 gene in adenocarcinoma and squamous cell carcinoma of the cervix: a systematic review. Gynecol Oncol (2012) 0.97

Progress towards development of an HIV vaccine: report of the AIDS Vaccine 2009 Conference. Lancet Infect Dis (2010) 0.96

Human papillomavirus (HPV) genotypes and HPV16 variants in human immunodeficiency virus-positive Italian women. J Gen Virol (2008) 0.96

Challenges in cancer vaccine development for hepatocellular carcinoma. J Hepatol (2013) 0.95

Gene profiling, biomarkers and pathways characterizing HCV-related hepatocellular carcinoma. J Transl Med (2009) 0.95

Hepatitis B virus genotype in Iranian patients with hepatocellular carcinoma. Int J Infect Dis (2009) 0.94

Evaluation of immunity against rubella in Iranian after mass campaign for measles-rubella vaccination on December 2003. Am J Infect Control (2006) 0.94

Virus-like particles as particulate vaccines. Curr HIV Res (2010) 0.94

Human papillomavirus is associated with breast cancer in the north part of Iran. ScientificWorldJournal (2012) 0.93

Vaccine-associated paralytic poliomyelitis in a patient with MHC class II deficiency. J Clin Virol (2007) 0.93

Prevalence of human papillomavirus genotypes and their variants in high risk West Africa women immigrants in South Italy. Infect Agent Cancer (2007) 0.92

Purification and characterization of a halophilic α-amylase with increased activity in the presence of organic solvents from the moderately halophilic Nesterenkonia sp. strain F. Extremophiles (2012) 0.92

Isolation of a type 3 vaccine-derived poliovirus (VDPV) from an Iranian child with X-linked agammaglobulinemia. Virus Res (2008) 0.92

Antibody response to influenza immunization in kidney transplant recipients receiving either azathioprine or mycophenolate: a controlled trial. Am J Nephrol (2008) 0.92

Gene expression profile of peripheral blood mononuclear cells in response to HIV-VLPs stimulation. BMC Bioinformatics (2008) 0.92

Translational fusion of chloroplast-expressed human papillomavirus type 16 L1 capsid protein enhances antigen accumulation in transplastomic tobacco. Transgenic Res (2008) 0.92

Hepatitis G virus exposure in dialysis patients. Int Urol Nephrol (2007) 0.91

Virus-like particle vaccines and adjuvants: the HPV paradigm. Expert Rev Vaccines (2009) 0.91

Developments in virus-like particle-based vaccines for infectious diseases and cancer. Expert Rev Vaccines (2011) 0.91

Prevalence of various human papillomavirus (HPV) genotypes among women who subjected to routine Pap smear test in Bushehr city (south west of Iran) 2008-2009. Virol J (2010) 0.91

Production, optimization and purification of a novel extracellular protease from the moderately halophilic bacterium Halobacillus karajensis. J Ind Microbiol Biotechnol (2008) 0.91

Molecular detection of respiratory viruses in clinical specimens from children with acute respiratory disease in Iran. Pediatr Infect Dis J (2010) 0.90

Comparison of cell culture with RT-PCR for enterovirus detection in stool specimens from patients with acute flaccid paralysis. J Clin Lab Anal (2007) 0.90

Surveillance of HIV drug resistance transmission in Iran: experience gained from a pilot study. Arch Virol (2010) 0.89

Antigen-specific vaccines for cancer treatment. Hum Vaccin Immunother (2014) 0.89

Guidelines of the Italian Society for Virology on HPV testing and vaccination for cervical cancer prevention. Infect Agent Cancer (2008) 0.89

Vaccine-associated paralytic poliomyelitis in immunodeficient children, Iran, 1995-2008. Emerg Infect Dis (2010) 0.89

Screening of HIV-1 isolates by reverse heteroduplex mobility assay and identification of non-B subtypes in Italy. J Acquir Immune Defic Syndr (2004) 0.89

Human herpesvirus type 8 variants circulating in Europe, Africa and North America in classic, endemic and epidemic Kaposi's sarcoma lesions during pre-AIDS and AIDS era. Virology (2010) 0.89

Differential gene expression between squamous cell carcinoma of esophageus and its normal epithelium; altered pattern of mal, akr1c2, and rab11a expression. World J Gastroenterol (2004) 0.88

Hepatitis G virus exposure in dialysis staff. Ther Apher Dial (2007) 0.88

Detection of mucosal and cutaneous human papillomaviruses in oesophagitis, squamous cell carcinoma and adenocarcinoma of the oesophagus. J Clin Virol (2009) 0.88

Kaposi's sarcoma: etiology and pathogenesis, inducing factors, causal associations, and treatments: facts and controversies. Clin Dermatol (2013) 0.87

Dendritic cells in the pathogenesis and treatment of human diseases: a Janus Bifrons? Immunotherapy (2011) 0.87

TP53 and MDM2 gene polymorphisms and risk of hepatocellular carcinoma among Italian patients. Infect Agent Cancer (2011) 0.87

Cardiac tamponade and heart failure due to myopericarditis as a presentation of infection with the pandemic H1N1 2009 influenza A virus. J Clin Microbiol (2010) 0.87

Systems biology applied to vaccine and immunotherapy development. BMC Syst Biol (2011) 0.85

Frequency of human papillomavirus infection in oesophageal squamous cell carcinoma in Iranian patients. Scand J Infect Dis (2007) 0.85

Novel BTK mutation presenting with vaccine-associated paralytic poliomyelitis. Eur J Pediatr (2008) 0.85